Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse.
about
Performance enhancement at the cost of potential brain plasticity: neural ramifications of nootropic drugs in the healthy developing brainPsychostimulants and cognition: a continuum of behavioral and cognitive activationAddiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulantsPotential adverse effects of amphetamine treatment on brain and behavior: a reviewThe complicated relationship between attention deficit/hyperactivity disorder and substance use disordersMethylphenidate normalizes resting-state brain dysfunction in boys with attention deficit hyperactivity disorderPersistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesisThe interactive effects of methylphenidate and ethanol on ethanol consumption and locomotor activity in miceCOMT Val108/158Met polymorphism and the modulation of task-oriented behavior in children with ADHD.Chronic methylphenidate exposure during adolescence reduces striatal synaptic responses to ethanol.Methylphenidate and the juvenile brain: enhancement of attention at the expense of cortical plasticity?Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors.Influence of sensitization on the discriminative stimulus effects of methylphenidate in mice.Methylphenidate and μ opioid receptor interactions: a pharmacological target for prevention of stimulant abuse.Amphetamine in adolescence disrupts the development of medial prefrontal cortex dopamine connectivity in a DCC-dependent mannerA pharmacokinetic model of oral methylphenidate in the rat and effects on behavior.Prenatal nicotine exposure mouse model showing hyperactivity, reduced cingulate cortex volume, reduced dopamine turnover, and responsiveness to oral methylphenidate treatment.Distinct age-dependent effects of methylphenidate on developing and adult prefrontal neurons.Fast quantitative determination of methylphenidate levels in rat plasma and brain ex vivo by MALDI-MS/MS.Infant rats exhibit aversive learning mediated by ethanol's orosensory effects but are positively reinforced by ethanol's post-ingestive effects.Interactive effects of methylphenidate and alcohol on discrimination, conditioned place preference and motor coordination in C57BL/6J miceStimulants: Therapeutic actions in ADHD.Novelty-induced conditioned place preference, sucrose preference, and elevated plus maze behavior in adult rats after repeated exposure to methylphenidate during the preweanling period.Kappa-opioid system regulates the long-lasting behavioral adaptations induced by early-life exposure to methylphenidate.Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization.Assessing appetitive, aversive, and negative ethanol-mediated reinforcement through an immature rat model.Dopamine-dependent periadolescent maturation of corticostriatal functional connectivity in mouse.Plasma and brain concentrations of oral therapeutic doses of methylphenidate and their impact on brain monoamine content in mice.A review of psychostimulant-induced neuroadaptation in developing animals.Evolution of the Study of Methylphenidate and Its Actions on the Adult Versus Juvenile Brain.Oral methylphenidate establishes a conditioned place preference in ratsThe discriminative stimulus properties of methylphenidate in C57BL/6J mice.Motivational effects of intraorally-infused ethanol in rat pups in an operant self-administration taskNicotinic receptors differentially modulate the induction and expression of behavioral sensitization to methylphenidate in rats.Controlled cortical impact injury influences methylphenidate-induced changes in striatal dopamine neurotransmission.Psychostimulants As Cognitive Enhancers in Adolescents: More Risk than Reward?Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat.Chronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats.Dopamine Development in the Mouse Orbital Prefrontal Cortex Is Protracted and Sensitive to Amphetamine in Adolescence.The effects of adolescent methylphenidate exposure on the behavioral and brain-derived neurotrophic factor response to nicotine.
P2860
Q21129314-7DAD2A0F-F5A1-4B48-961B-DB53B6EB1900Q22242285-E54F6D2F-BD51-4A4B-9B34-5C1D0A673D30Q22251215-F13ADFC9-2DD7-468B-B658-E8F5E6202E95Q24657966-E3C964AC-A976-4EB2-83B9-95317141F60EQ26851607-583998D3-15B3-4831-A957-612EEB3E2620Q28703539-9BDDF5F7-58AB-4424-B88A-FE61C8800EE2Q33589580-2BE22B1F-1612-4E99-9718-21F643E7A3D6Q33822439-74099154-16A4-497B-B4F4-E83249E6B4A6Q33911088-0C3CAE37-16E9-4E6D-9FFE-28AF36277661Q34180506-D1DE75B6-7E4D-46BE-85A1-3A2F53E8DF35Q34375450-5F9FA569-AFA2-4FC5-B3D6-D598DDB84E4CQ34394916-989B08DD-E87F-4730-BE0E-099AE1B44DFFQ34437715-A89E2B05-73B1-41CE-9D80-AD8394625403Q35016913-4AA157BF-8A90-40FF-8D80-7E0355DFBADAQ35199981-C77E7AC4-7454-4D4F-8DDC-7CC7F0CCE242Q35709161-071A0CD0-B143-400B-8D68-279279175432Q36157627-A227149D-A11F-48C2-BFB7-5CC64C2849EBQ36208021-2F4FE24A-7CA6-4018-8A6F-EB16C83F0A97Q36321707-634CF696-429A-4299-B127-FA633C9C0C29Q36514214-08F5E755-14A1-4699-B09E-091AA8333CADQ36539767-803A21EB-3132-426E-9158-5BE6FDBDBF50Q36541590-17597307-E443-4673-984A-E9FD5155E15DQ36796650-1B5316C9-3295-4E0E-98B8-3A0178474B58Q37130532-EC3527CE-7E42-496F-A582-E2EA21574273Q37147049-03402241-F11E-4024-85DC-BD40DA1EF256Q37221255-64DDB372-DDD5-48E3-A503-B25AEC48BF91Q37344204-763AB111-EEF9-475D-9972-9A494A32BC28Q37438542-95E21681-18FF-43B6-985F-E8E8FCFF3EFAQ37879918-92C97A57-46D7-4744-98B3-2033945B1D8AQ38038163-53521D34-DC1C-4D8B-A1F2-788493C5689AQ41483014-84E1A87F-5AC0-46A0-8747-35B002513EB3Q41952193-70827ED6-D778-4CCD-8499-98DCCE596AC8Q41979789-4A0A42B1-8906-4270-8843-57DE64F502B2Q42091700-1E19DA9E-A5CA-4272-9BE7-DDCF9D31DE65Q42099064-0AD2CD1E-A83A-4BBD-9E5E-8D03F37492E7Q42369862-A37B038F-23E5-439A-95B6-B4E08A4246E1Q46456427-F30C4C7C-419D-4D57-82CE-0D5A4C294A30Q47338555-8DC99D6A-5A97-4FD8-B863-A29FE26FD68BQ47553717-86BA6BEE-F235-453E-8380-8A2EB00F81A8Q47610392-2911956F-CAA5-4986-9BEA-B86DEF8CBB72
P2860
Stimulant actions in rodents: implications for attention-deficit/hyperactivity disorder treatment and potential substance abuse.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Stimulant actions in rodents: ...... and potential substance abuse.
@ast
Stimulant actions in rodents: ...... and potential substance abuse.
@en
Stimulant actions in rodents: ...... and potential substance abuse.
@nl
type
label
Stimulant actions in rodents: ...... and potential substance abuse.
@ast
Stimulant actions in rodents: ...... and potential substance abuse.
@en
Stimulant actions in rodents: ...... and potential substance abuse.
@nl
prefLabel
Stimulant actions in rodents: ...... and potential substance abuse.
@ast
Stimulant actions in rodents: ...... and potential substance abuse.
@en
Stimulant actions in rodents: ...... and potential substance abuse.
@nl
P1476
Stimulant actions in rodents: ...... and potential substance abuse.
@en
P2093
David S Segal
Ronald Kuczenski
P304
P356
10.1016/J.BIOPSYCH.2004.12.036
P407
P577
2005-06-01T00:00:00Z